(Q42252556)

19 October 2017

Her-2/neu oncogene amplification in clinically localised prostate cancer (English)

1 reference

19 October 2017

1 reference

Oxley JD

1

1 reference

19 October 2017

Winkler MH

series ordinal

2

1 reference

19 October 2017

Gillatt DA

series ordinal

3

1 reference

19 October 2017

Peat DS

series ordinal

4

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Journal of Clinical Pathology

19 October 2017

1 reference

19 October 2017

55

1 reference

19 October 2017

2

1 reference

19 October 2017

118-120

1 reference

Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769579

Striking increase in incidence of prostate cancer in men aged < 60 years without improvement in prognosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769579

HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769579

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769579

Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769579

Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769579

Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769579

Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis

17 August 2018

1 reference

12 December 2020

Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models

1 reference

12 December 2020

Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas

1 reference

12 December 2020

Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy

1 reference

12 December 2020

Fluorescence in situ hybridization study of HER-2/neu oncogene amplification in prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.55.2.118

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

11865006

1 reference